Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Non-Current Deferred Tax Liability: 2016-2021

Historic Non-Current Deferred Tax Liability for cbdMD (YCBD) over the last 3 years, with Sep 2021 value amounting to $6.1 million.

  • cbdMD's Non-Current Deferred Tax Liability rose 583.35% to $6.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $6.1 million, marking a year-over-year increase of 583.35%. This contributed to the annual value of $6.1 million for FY2021, which is 583.35% up from last year.
  • Per cbdMD's latest filing, its Non-Current Deferred Tax Liability stood at $6.1 million for Q3 2021, which was up 4,604.62% from $130,000 recorded in Q2 2021.
  • cbdMD's 5-year Non-Current Deferred Tax Liability high stood at $6.1 million for Q3 2021, and its period low was $15,000 during Q4 2017.
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $1.9 million (2019), whereas its average is $2.5 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first skyrocketed by 33,206.67% in 2018, then crashed by 83.33% in 2020.
  • cbdMD's Non-Current Deferred Tax Liability (Quarterly) stood at $15,000 in 2017, then skyrocketed by 33,206.67% to $5.0 million in 2018, then surged by 1,358.97% to $5.4 million in 2019, then tumbled by 83.33% to $563,000 in 2020, then surged by 583.35% to $6.1 million in 2021.
  • Its Non-Current Deferred Tax Liability was $6.1 million in Q3 2021, compared to $130,000 in Q2 2021 and $27,000 in Q1 2021.